CAPORALI, ROBERTO FELICE
CAPORALI, ROBERTO FELICE
Dipartimento di Scienze Cliniche e di Comunità
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry
2024 A. Manfredi, M. Fornaro, C. Bazzani, S. Perniola, A. Cauli, A. Rai, E.G. Favalli, S. Bugatti, M. Rossini, R. Foti, F. Conti, G. Lopalco, A. Scalvini, C. Garufi, M. Congia, R. Gorla, E. Gremese, F. Atzeni, R. Caporali, F. Iannone, M. Sebastiani
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
2024 F.S. Macaluso, F. Caprioli, L. Benedan, C. Bezzio, R. Caporali, A. Cauli, M.S. Chimenti, F. Ciccia, S. D'Angelo, M.C. Fantini, S. Festa, F. Iannone, E. Lubrano, P. Mariani, C. Papi, G. Provenzano, D. Pugliese, A. Rispo, S. Saibeni, C. Salvarani, A. Variola, M. Zenga, A. Armuzzi, A. Orlando, R. Gerli
Disease activity and disease-related factors are drivers of patient global assessment in rheumatoid arthritis: a real-life cross-sectional study
2023 I. Suardi, C. Posio, E. Luconi, P. Boracchi, R. Caporali, F. Ingegnoli
Case report: Prader-Willi syndrome and inflammatory arthritis-An important consideration
2023 L. Marelli, T. Dallos, E. Miserocchi, P. Nucci, B. Tombolini, O. De Lucia, M. Gattinara, R. Caporali, A. Marino
Does Pizza Consumption Favor an Improved Disease Activity in Rheumatoid Arthritis?
2023 R. De Vito, M. Parpinel, M.C. Speciani, F. Fiori, R. Bianco, R. Caporali, F. Ingegnoli, I. Scotti, T. Schioppo, T. Ubiali, M. Cutolo, G. Grosso, M. Ferraroni, V. Edefonti
Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia
2023 C. Crotti, F. Zucchi, C. Alfieri, R. Caporali, M. Varenna
Effect of neridronate on axial involvement in patients with spondyloarthritis when biologics are not possible. Results of a monocentric study
2023 C. Crotti, R. Di Taranto, F. Orsini, M. Ferrito, M. Varenna, E.G. Favalli, R. Caporali
Rheumatoid Arthritis from Easy to Complex Disease: From the “2022 GISEA International Symposium”
2023 S. Perniola, M.S. Chimenti, F.R. Spinelli, B. Frediani, R. Foti, S. Ferrigno, C. Garufi, G. Cassone, V. Venerito, F. Atzeni, R. Caporali, F. Conti, E.G. Favalli, F. Iannone, M. Sebastiani, G.F. Ferraccioli, G. Lapadula, E. Gremese
From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium”
2023 A. Vitale, S. Alivernini, R. Caporali, G. Cassone, D. Bruno, L. Cantarini, G. Lopalco, M. Rossini, F. Atzeni, E.G. Favalli, F. Conti, E. Gremese, F. Iannone, G.F. Ferraccioli, G. Lapadula, M. Sebastiani
The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events
2023 E.G. Favalli, G. Cincinelli, S. Germinario, R. Di Taranto, F. Orsini, G. Maioli, M. Biggioggero, M. Ferrito, R. Caporali
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission
2023 R. Giacomelli, R. Caporali, F. Ciccia, S. Colafrancesco, L. Dagna, M. Govoni, F. Iannone, P. Leccese, C. Montecucco, G. Pappagallo, G. Pistone, R. Priori, P. Ruscitti, P. Sfriso, L. Cantarini, N. Belfiore, C. Bernardi, M. Gabini, S. Bettio, A. Brucato, G. Italiano, F.P. Cantatore, D. Iacono, I. Pantano, E. Tirri, F. Ursini, A.L. Monaco, F. Caso, L. Quartuccio, M.S. Chimenti, A. Gattamelata, E. Gremese, M. Paroli, A. Picchianti-Diamanti, G.D. Sebastiani, E. Favalli, A. Sulli, M. Frassi, P. Faggioli, R. Foti, C. Campochiaro, G. Cavalli, A. Tomelleri, M. Manara, L. De Stefano, R. De Angelis, S. Parisi, G. Lopalco, M. Piga, D. Marotto, M. Colaci, A. Padula, G. Guggino, G. Emmi, C. Baldini, J. Sota, A. Vitale, A. Berti, E. Bartoloni, C. Grava, S. Bindoli, R. Vitetta
Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'
2023 C. Perricone, E. Bartoloni, G. Cafaro, R. Caporali, R. Gerli
Olive Oil and Nuts in Rheumatoid Arthritis Disease Activity
2023 R. De Vito, F. Fiori, M. Ferraroni, S. Cavalli, R. Caporali, F. Ingegnoli, M. Parpinel, V. Edefonti
Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients
2023 M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali
Owning Pets Reduces the Perception of Disease Activity in Patients With Rheumatoid Arthritis
2023 C. Posio, I. Suardi, R. Caporali, F. Ingegnoli
Tight control in patients with rheumatoid arthritis treated with targeted therapies across the COVID-19 pandemic era
2023 A.F. Luppino, G. Cincinelli, A. Orenti, P. Boracchi, E.G. Favalli, R. Caporali, F. Ingegnoli
Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study
2023 G.A. Ramirez, M. Gerosa, C. Bellocchi, D. Arroyo-Sánchez, C. Asperti, L.M. Argolini, G. Gallina, M. Cornalba, I. Scotti, I. Suardi, L. Moroni, L. Beretta, E.P. Bozzolo, R. Caporali, L. Dagna
Long-term use of burosumab for the treatment of tumor-induced osteomalacia
2023 C. Crotti, F. Zucchi, C. Alfieri, R. Caporali, M. Varenna
Correspondence on 'Non-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitation'
2023 P. Randelli, L.A. Coletto, A. Menon, R. Caporali
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort
2022 M. Gerosa, L. Beretta, G.A. Ramirez, E. Bozzolo, M. Cornalba, C. Bellocchi, L.M. Argolini, L. Moroni, N. Farina, G. Segatto, L. Dagna, R. Caporali